MGTA-117 Antibody
Product Specifications
Target
ADC Antibody
Related Pathways
Antibody-drug Conjugate/ADC Related
Bioactivity
MGTA-117 is a humanized monoclonal antibody that targets CD117. It carries an amanitin payload and is used to synthesize antibody-drug conjugates (ADC) . MGTA-117 demonstrates potent antitumor activity, enhancing survival in three acute myeloid leukemia (AML) xenograft models [Kasumi-1, AML PDX 1, and AML PDX 2]. It is applicable for AML, myelodysplastic syndromes with excess blasts (MDS-EB), and preconditioning for hematopoietic stem cell transplantation (HSCT) in gene therapy.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6391179-01 0.1 mL
PSMD5 (26S Proteasome non-ATPase Regulatory Subunit 5, 26S Proteasome Subunit S5B, 26S Protease Subunit S5 Basic, KIAA0072) (FITC)
Ask
View Details 
MBS6391179-02 5x 0.1 mL
PSMD5 (26S Proteasome non-ATPase Regulatory Subunit 5, 26S Proteasome Subunit S5B, 26S Protease Subunit S5 Basic, KIAA0072) (FITC)
Ask
View Details QP7980-ec-500ug 500ug
Recombinant Human Proteasome inhibitor PI31 subunit Protein, His-SUMO, E.coli-500ug
Ask
View Details